SRSF1 and lung cancer: Depletion of SRSF1 in human A549 lung cancer cells reduces IFN-β through the expression of alternative IRF3 spliced variants [10], while SF3A1 silencing leads to a decreased induction of pro-inflammatory cytokines by promoting an alternative splice form of MyD88 [11].